Anti-TMPRSS-11E Rabbit Polyclonal Antibody

Rabbit Polyclonal
WB
Citation tracking pending
Rabbit polyclonal antibody raised against the cytoplasmic domain of human TMPRSS-11E (DESC1, Q9UL52); validated for WB.
Host
Rabbit, Polyclonal
Reactivity
Validated- Human Potential-Mouse, Rat, Monkey, Dog
UniProt
Q9UL52
Size
100ug
Cat. #
RP3TMPRSS11E

In stock

SKU
RP-TMPRSS11E

Options

As low as: $130.00

Target Overview

Transmembrane protease serine 11E (TMPRSS-11E; UniProt Q9UL52), also known as DESC1 (differentially expressed in squamous cell carcinoma 1), is a 423-residue type II transmembrane serine protease (EC 3.4.21.-) belonging to the TMPRSS/HAT-DESC subfamily. The protein is anchored at the cell membrane via an N-terminal signal anchor, with an extracellular SEA domain followed by a trypsin-like serine protease catalytic domain. Autocatalytic activation generates a non-catalytic chain that remains membrane-tethered and a catalytic chain held to the surface by a disulfide bond. The mature enzyme exhibits gelatinolytic and caseinolytic activity and shows a strong preference for arginine at the P1 position. TMPRSS-11E expression has been documented in stratified squamous epithelia of the upper aerodigestive tract, skin, and esophagus, with additional reports of expression on macrophages and selected tumor tissues. Substrate cleavage at the cell surface places TMPRSS-11E in pathways that include pericellular matrix remodeling, growth factor maturation, and proteolytic priming of viral envelope glycoproteins. Recent work has linked the protease to SARS-CoV-2 macrophage entry, porcine deltacoronavirus entry into Huh7 cells, and cleavage of transferrin receptor 1 (TFR1) with downstream effects on interferon-γ receptor internalization. The catalogue offers three rabbit polyclonal antibodies (RP1TMPRSS11E, RP2TMPRSS11E, RP3TMPRSS11E) raised against the cytoplasmic domain, allowing detection of full-length TMPRSS-11E and the membrane-retained non-catalytic chain in human samples, with predicted cross-reactivity to mouse, rat, monkey, and dog orthologs based on sequence conservation.

Background

TMPRSS-11E was initially characterized as DESC1, a protease with restricted expression in squamous epithelia and reduced transcript levels in head and neck squamous cell carcinoma. Like other TMPRSS family members (TMPRSS2, HAT, matriptase), it functions as a pericellular protease whose activity is tightly compartmentalized to the apical or basolateral surface of polarized epithelia. The trypsin-like catalytic domain cleaves substrates after basic residues, and reported in vitro activity on gelatin and casein is consistent with a role in extracellular matrix turnover. Viral entry has emerged as a major area of interest. TMPRSS-11E can prime coronavirus spike glycoproteins for membrane fusion, analogous to TMPRSS2. Wang et al. (2026, Respir Res) described a surface CD98/TMPRSS11E complex that mediates SARS-CoV-2 entry into macrophages and biases polarization toward proinflammatory M1 phenotypes, providing a mechanistic link between protease expression and COVID-19 immunopathology. Xiao et al. (2025, J Virol) reported that TMPRSS-11E together with cathepsin L supports trypsin-independent entry of porcine deltacoronavirus into Huh7 cells, broadening the protease's relevance to cross-species coronavirus tropism. Beyond viral priming, TMPRSS-11E shapes innate immune signaling. Wang et al. (2025, Commun Biol) showed that TMPRSS-11E cleaves transferrin receptor 1 (TFR1) at the macrophage surface and alters IFN-γR2 internalization kinetics, modulating the response to interferon-γ. In oncology, TMPRSS11E has been incorporated into prognostic gene signatures for lung adenocarcinoma (Shu et al., 2023, Front Immunol) and into genomic instability–derived predictors for non-small cell lung cancer (Li et al., 2023, Cancer Genet), suggesting transcriptional dysregulation in pulmonary malignancy. Antibodies directed at the cytoplasmic tail are useful for detecting both unprocessed zymogen and the membrane-retained non-catalytic chain following autoactivation, an important consideration when interpreting Western blot banding patterns in primary tissue.

References

  1. Wang T et al (2026) The macrophage entry mechanism of SARS-CoV-2 mediated by surface CD98/TMPRSS11E complex is associated with the cellular tropism toward proinflammatory M1 and pathogenesis. Respir Res. PubMed · DOI.
  2. Wang T et al (2025) TMPRSS11E-mediated TFR1 cleavage influences IFN-γR2 internalization and the macrophage innate response. Commun Biol. PubMed · DOI.
  3. Xiao W et al (2025) Cathepsin L and transmembrane serine protease 11E mediate trypsin-independent entry of porcine deltacoronavirus into Huh7 cells. J Virol. PubMed · DOI.
  4. Shu J et al (2023) Identification of novel gene signature for lung adenocarcinoma by machine learning to predict immunotherapy and prognosis. Front Immunol. PubMed · DOI.
  5. Li W et al (2023) Construction of a genomic instability-derived predictive prognostic signature for non-small cell lung cancer patients. Cancer Genet. PubMed · DOI.

Additional Specifications

Gene Symbol TMPRSS11E
UniProt ID Q9UL52
Host Species Rabbit
Species Reactivity Validated- Human
Potential-Mouse, Rat, Monkey, Dog
Pack Size 100ug
Immunogen (Cytoplasmic domain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 1-19.
Immunogen (SEA Domain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 50-170.
Immunogen (Catalytic domain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 192-422.
Alternate Names TMPRSS11E, DESC1, Serine protease DESC1, Transmembrane protease serine 11E, Transmembrane protease serine 11E2, TMPRSS11E2, Differentially expressed in squamous cell carcinoma 1, EC 3.4.21.-

Frequently Asked Questions

What molecular weight should I expect for TMPRSS-11E on Western blot?

TMPRSS-11E migrates as a full-length precursor at approximately 47 kDa. Following autocatalytic activation, you may observe two chains: a non-catalytic N-terminal fragment (~18-20 kDa) that remains membrane-anchored and a catalytic C-terminal fragment (~27-30 kDa) linked by a disulfide bond. Under reducing conditions, both fragments should be visible. The banding pattern depends on cell activation state and protease activity in your sample. Keratinocyte or squamous carcinoma lysates often show mixed precursor and processed forms.

What is the recommended starting dilution for TMPRSS-11E antibody in Western blot?

Start at 1:1000 dilution in blocking buffer for overnight incubation at 4°C or 1-2 hours at room temperature. This polyclonal antibody was raised against a large fragment spanning residues 46-460, providing robust signal in validated human samples. If background is high, titrate to 1:2000. If signal is weak in low-expression samples, increase antibody concentration to 1:500. Always include a positive control lysate from stratified squamous epithelium or a relevant carcinoma line to confirm antibody performance before troubleshooting dilution.

Does this antibody cross-react with other TMPRSS family members?

The immunogen spans a large portion of TMPRSS-11E (residues 46-460), which includes both the SEA domain and catalytic domain. While this antibody is validated for human TMPRSS-11E, the TMPRSS/HAT-DESC subfamily shares structural homology. We have not observed cross-reactivity with closely related family members in our validation, but if you are working with samples expressing multiple TMPRSS proteases, consider running siRNA knockdown or knockout controls alongside wild-type lysates to confirm band specificity. Sequence alignment suggests minimal cross-reactivity risk with TMPRSS-2, -4, or -13.

Will this rabbit polyclonal antibody work in mouse or rat samples?

Mouse and rat cross-reactivity are predicted based on sequence homology in the immunogen region, but not yet validated in-house. If you are working with murine models, we recommend confirming reactivity in a pilot Western blot using mouse esophageal or forestomach epithelium as a positive control, as these tissues express TMPRSS-11E orthologs. Start with the same 1:1000 dilution used for human samples. Monkey and dog reactivity are also predicted due to high conservation in the catalytic and SEA domains across mammals.

What tissues or cell lines are good positive controls for TMPRSS-11E expression?

TMPRSS-11E is predominantly expressed in stratified squamous epithelia. For human samples, esophageal epithelium, oral mucosa, or skin keratinocytes serve as strong positive controls. Among cancer cell lines, squamous cell carcinoma lines (head and neck, esophageal, or cervical origin) often show robust expression. Normal simple epithelia or mesenchymal cells typically lack TMPRSS-11E and make useful negative controls. Differential expression was originally noted in squamous carcinoma versus normal tissue, so pairing tumor and matched normal lysates can validate both antibody specificity and your experimental model.

Can I use this antibody for immunohistochemistry or immunofluorescence on TMPRSS-11E?

Yes. Triple Point Biologics antibodies are validated for Western blot and immunohistochemistry, and many perform well in immunofluorescence. For IHC on paraffin sections, antigen retrieval is typically required—citrate buffer (pH 6.0) heat-induced retrieval is a standard starting point for transmembrane proteases. For IF, use methanol or paraformaldehyde fixation depending on epitope accessibility. Because TMPRSS-11E is a membrane protein with extracellular domains, cell-surface staining should be visible in non-permeabilized live-cell or fixed monolayers. Titrate the antibody starting at 1:100 to 1:200 for IHC and IF applications.

How should I store the TMPRSS-11E antibody and what is the expected shelf life?

Store the antibody at -20°C in single-use aliquots to avoid repeated freeze-thaw cycles, which can reduce titre and increase aggregation. The 100 µg pack size is suitable for aliquoting into 10-20 µL volumes for typical lab use. Polyclonal antibodies in glycerol-containing storage buffer remain stable for at least two years at -20°C. For short-term use (up to one month), an aliquot can be kept at 4°C. Do not store diluted antibody in working solution; prepare fresh dilutions for each experiment to maintain consistent performance and minimize microbial contamination.

What sample preparation considerations are important for detecting TMPRSS-11E activity and cleavage?

Because TMPRSS-11E undergoes autocatalytic activation, sample handling affects the precursor-to-cleaved ratio. Snap-freeze tissues in liquid nitrogen or lyse cells quickly in the presence of protease inhibitors (AEDANS, aprotinin, or serine protease-specific cocktails) to preserve the activation state. If you aim to study proteolytic processing, omit or reduce protease inhibitors, but process samples immediately on ice. Membrane proteins benefit from RIPA or Triton X-100 lysis buffers; avoid SDS-only extraction, which can cause aggregation. Reducing agents (DTT or β-mercaptoethanol) will separate disulfide-linked chains during SDS-PAGE.

Western blot validation for RP-TMPRSS11E — 2 panels across the domain-specific antibody variants. Each blot below shows the clone that validates a specific domain of the target protein.

TMPRSS-11E: SEA Domain — WB validation
WB · Panel 1 TMPRSS-11E: SEA Domain
TMPRSS-11E: Catalytic domain — WB validation
WB · Panel 2 TMPRSS-11E: Catalytic domain

Custom validation studies available on request — contact us.

Also known as:

  • TMPRSS11E
  • DESC1
  • Serine protease DESC1
  • Transmembrane protease serine 11E
  • Transmembrane protease serine 11E2
  • TMPRSS11E2
  • Differentially expressed in squamous cell carcinoma 1
  • EC 3.4.21.-
  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →